Today

Agents

Chat

Arena

Discover

More

App

DKSH acquires Rocephin from Roche - RHHBY News | Rallies

DKSH acquires Rocephin from Roche

RHHBY•2026-10-28

DKSH acquired rights to Rocephin from Roche in more than 80 markets, expanding its healthcare own brands portfolio.

1. Acquisition details

DKSH said it acquired rights to Rocephin from Roche in more than 80 markets, expanding its healthcare own brands portfolio.

Related News

F5, Inc.: RBC raises target price to $540 from $525

FFIV•2026-10-28

Deutsche Bank assets under management rise to nearly EUR 2 trillion

DB•2026-10-28

GSK beats third-quarter profit estimates, keeps annual targets

GSK•2026-10-28

American Tower Corporation: JPMorgan cuts target price to $230 from $240

AMT•2026-10-28

TD Cowen raises Beta Bionics target price to $21 from $18

BBNX•2026-10-28